SPDR S&P Biotech ETF
755 hedge funds and large institutions have $9.15B invested in SPDR S&P Biotech ETF in 2024 Q2 according to their latest regulatory filings, with 88 funds opening new positions, 252 increasing their positions, 253 reducing their positions, and 97 closing their positions.
Holders
755
Holders Change
-19
Holders Change %
-2.45%
% of All Funds
10.98%
Holding in Top 10
18
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-21.74%
% of All Funds
0.26%
New
88
Increased
252
Reduced
253
Closed
97
Calls
$1.59B
Puts
$2.95B
Net Calls
-$1.36B
Net Calls Change
+$358M
Top Buyers
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$6.3M |
| 2 |
2
Citigroup
New York
|
$673M |
| 3 |
CHP
3
Castle Hook Partners
New York
|
$19.8M |
| 4 |
ACA
4
Avoro Capital Advisors
New York
|
$281M |
| 5 |
5
Morgan Stanley
New York
|
$595M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ECU
876
Eisler Capital (US)
New York
| – | – | – | – |
|
|
PHK
877
Point72 Hong Kong
Hong Kong
| – | – | – | – |
|
|
VCIM
878
Velan Capital Investment Management
Alpharetta,
Georgia
| – | – | – | – |
|
|
ECM
879
ExodusPoint Capital Management
New York
| – | – | – | – |
|
880
Point72 Asset Management
Stamford,
Connecticut
| – | – | – | – |
|
|
LGM
881
Logos Global Management
San Francisco,
California
| – | – | – | – |
|
|
GL
882
Governors Lane
New York
| – | – | – | – |
|
|
LP
883
LMR Partners
London,
United Kingdom
| – | – | – | – |
|
884
Capital Fund Management (CFM)
Paris,
France
| – | – | – | – |
|
|
OIM
885
Oracle Investment Management
Greenwich,
Connecticut
| – | – | – | – |
|